FROM MIRACLE DRUGS TO GLOBAL RESISTANCE: THE HUMAN COST OF ANTIBIOTIC MISUSE

Abstract

The discovery of antibiotics revolutionized modern medicine and transformed the treatment of infectious diseases, dramatically reducing global mortality and increasing human life expectancy throughout the twentieth century. What was once considered a definitive victory over bacterial infections, however, has progressively evolved into one of the greatest public health threats of the modern era. After nearly eight decades of widespread antibiotic exposure, humanity now faces the accelerating emergence of antimicrobial resistance (AMR), a phenomenon driven largely by inappropriate, excessive, and poorly regulated antimicrobial use across human medicine, veterinary practice, agriculture, and the environment. The current resistance crisis reflects decades of selective pressure imposed on microbial ecosystems. Antibiotics have been excessively prescribed for viral illnesses, used empirically without adequate diagnostic confirmation, consumed through self-medication, and extensively incorporated into livestock production for disease prevention and growth promotion. Simultaneously, inadequate infection control practices, environmental contamination, globalization, and insufficient antimicrobial stewardship have facilitated the rapid dissemination of multidrug-resistant pathogens worldwide. The consequence has been the emergence of highly resistant organisms capable of compromising the effectiveness of even last-line therapies. Beyond its microbiological dimension, AMR threatens the foundation of modern healthcare systems. Procedures that depend on effective antibiotics, including organ transplantation, chemotherapy, intensive care medicine, and major surgery are becoming increasingly vulnerable to therapeutic failure. Resistant infections are associated with prolonged hospitalization, increased mortality, escalating healthcare expenditures, and substantial economic losses that are projected to reach trillions of dollars over the coming decades. Although promising alternatives such as vaccines, bacteriophage therapy, antimicrobial peptides, precision medicine, and artificial intelligence-based drug discovery are under development, none currently possess the capacity to fully replace conventional antibiotics. Until innovative therapeutic strategies become broadly available, preserving the effectiveness of existing antimicrobials through rational prescribing, surveillance, infection prevention, and coordinated global stewardship policies remains one of the most urgent priorities in contemporary medicine.